
The Food and Drug Administration said it did not expect “any immediate significant impacts on supply” after a tornado damaged a Pfizer plant in North Carolina that makes sterile injectables for U.S. hospitals, but is working with Pfizer to complete a more extensive assessment and will share more information as it becomes available.